INTERDISCIPLINARY APPROACHES IN DRUG DISCOVERY: FROM MOLECULES TO MEDICINE

Introduction
The drug discovery landscape has evolved dramatically with the convergenceof multiple scientific disciplines. Traditional approaches are increasinglycomplemented by breakthroughs in molecular biology, computational chemistry, artificial intelligence, and material sciences. This interdisciplinary integrationis
crucial to overcoming the growing complexity of modern diseases and acceleratingthe path from molecule identification to clinically viable therapies. Problem Statement
Despite significant advancements in pharmaceutical sciences, the time andcost involved in bringing a new drug to market remain high. This research highlights
the role of interdisciplinary strategies in enhancing efficiency and innovationthroughout the drug discovery pipeline. It particularly examines howcollaborativeinput from pharmacologists, chemists, data scientists, and clinicians can identifyviable drug candidates more effectively. Key findings
Where interdisciplinary collaboration has led to success, including:
Structure-based drug design using computational models,
INTERDISCIPLINARY
APPROACHES IN DRUG
DISCOVERY: FROMMOLECULES TO MEDICINE
AI-assisted screening of compound libraries, Target validation through genomics and proteomics and
Novel delivery systems engineered through nanotechnology
Conclusion
The future of drug discovery lies in fostering strong interdisciplinary networks. By breaking down traditional research silos, the pharmaceutical industry can adapt
more quickly to emerging challenges, ensure patient centric solutions, and ultimatelydeliver safer and more effective treatments. Keywords: Interdisciplinary research, Drug discovery, AI in pharmacology, Nanotechnology, Personalized medicine